What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis

Abstract Purpose Spinal metastases are indicative of progressive cancer which can lead to vertebral body fractures and spinal cord compression. Radiofrequency ablation (RFA) treatment is infrequently used in patients with refractory pain. The aim of this systematic review is to determine the clinica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Navanith Murali, Thomas Turmezei, Sumbal Bhatti, Puja Patel, Thomas Marshall, Toby Smith
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/61b7f076bc6848ad8d27900d8b753f0c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:61b7f076bc6848ad8d27900d8b753f0c
record_format dspace
spelling oai:doaj.org-article:61b7f076bc6848ad8d27900d8b753f0c2021-11-08T11:01:44ZWhat is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis10.1186/s13018-021-02775-x1749-799Xhttps://doaj.org/article/61b7f076bc6848ad8d27900d8b753f0c2021-11-01T00:00:00Zhttps://doi.org/10.1186/s13018-021-02775-xhttps://doaj.org/toc/1749-799XAbstract Purpose Spinal metastases are indicative of progressive cancer which can lead to vertebral body fractures and spinal cord compression. Radiofrequency ablation (RFA) treatment is infrequently used in patients with refractory pain. The aim of this systematic review is to determine the clinical efficacy of RFA, with the scope of using it as front-line management of spinal metastases. Methods Electronic databases were searched (to July 2020) for studies evaluating RFA treatment for spinal metastases in adults. Measured outcomes were pain (primary), disability, health-related quality of life (HRQOL), complications, tumour control and mortality. Study inclusion, data extraction and risk of bias using the ROBIN-I tool were assessed. Meta-analysis was conducted for pooled results with homogeneity, and narrative synthesis was conducted otherwise. Results 15 studies were included. RFA reduces pain scores at 3–5 weeks [standardised mean difference (SMD 2.24, 95% confidence intervals (CI) 1.55–2.93], 3–4 months (SMD 3.00, 95% CI 1.11–4.90) and 5–6 months (SMD 3.54, 95% CI 1.96–5.11). RFA is effective in reducing disability/improving HRQOL in the short-term but longer-term efficacy remains unclear. 13.2% cases reported local tumour control failure (2.5 months–5 year follow-up) whereas mortality was 23.6% (follow-up of up to 1 year). Conclusion Low quality evidence has proven RFA to be safe and effective in reducing pain and disability, especially in the short-term. RFA may be routinely implemented in all cases involving refractory pain or radiotherapy-resistant tumours but controlled trials are required to compare the efficacy of RFA to current frontline treatments. PROSPERO protocol registration number: CRD42020202377.Navanith MuraliThomas TurmezeiSumbal BhattiPuja PatelThomas MarshallToby SmithBMCarticleSpinal metastasesRadiofrequency ablationSpinal cord compressionBack painRadiotherapyOrthopedic surgeryRD701-811Diseases of the musculoskeletal systemRC925-935ENJournal of Orthopaedic Surgery and Research, Vol 16, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Spinal metastases
Radiofrequency ablation
Spinal cord compression
Back pain
Radiotherapy
Orthopedic surgery
RD701-811
Diseases of the musculoskeletal system
RC925-935
spellingShingle Spinal metastases
Radiofrequency ablation
Spinal cord compression
Back pain
Radiotherapy
Orthopedic surgery
RD701-811
Diseases of the musculoskeletal system
RC925-935
Navanith Murali
Thomas Turmezei
Sumbal Bhatti
Puja Patel
Thomas Marshall
Toby Smith
What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis
description Abstract Purpose Spinal metastases are indicative of progressive cancer which can lead to vertebral body fractures and spinal cord compression. Radiofrequency ablation (RFA) treatment is infrequently used in patients with refractory pain. The aim of this systematic review is to determine the clinical efficacy of RFA, with the scope of using it as front-line management of spinal metastases. Methods Electronic databases were searched (to July 2020) for studies evaluating RFA treatment for spinal metastases in adults. Measured outcomes were pain (primary), disability, health-related quality of life (HRQOL), complications, tumour control and mortality. Study inclusion, data extraction and risk of bias using the ROBIN-I tool were assessed. Meta-analysis was conducted for pooled results with homogeneity, and narrative synthesis was conducted otherwise. Results 15 studies were included. RFA reduces pain scores at 3–5 weeks [standardised mean difference (SMD 2.24, 95% confidence intervals (CI) 1.55–2.93], 3–4 months (SMD 3.00, 95% CI 1.11–4.90) and 5–6 months (SMD 3.54, 95% CI 1.96–5.11). RFA is effective in reducing disability/improving HRQOL in the short-term but longer-term efficacy remains unclear. 13.2% cases reported local tumour control failure (2.5 months–5 year follow-up) whereas mortality was 23.6% (follow-up of up to 1 year). Conclusion Low quality evidence has proven RFA to be safe and effective in reducing pain and disability, especially in the short-term. RFA may be routinely implemented in all cases involving refractory pain or radiotherapy-resistant tumours but controlled trials are required to compare the efficacy of RFA to current frontline treatments. PROSPERO protocol registration number: CRD42020202377.
format article
author Navanith Murali
Thomas Turmezei
Sumbal Bhatti
Puja Patel
Thomas Marshall
Toby Smith
author_facet Navanith Murali
Thomas Turmezei
Sumbal Bhatti
Puja Patel
Thomas Marshall
Toby Smith
author_sort Navanith Murali
title What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis
title_short What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis
title_full What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis
title_fullStr What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis
title_full_unstemmed What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis
title_sort what is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? a systematic review and meta-analysis
publisher BMC
publishDate 2021
url https://doaj.org/article/61b7f076bc6848ad8d27900d8b753f0c
work_keys_str_mv AT navanithmurali whatistheeffectivenessofradiofrequencyablationinthemanagementofpatientswithspinalmetastasesasystematicreviewandmetaanalysis
AT thomasturmezei whatistheeffectivenessofradiofrequencyablationinthemanagementofpatientswithspinalmetastasesasystematicreviewandmetaanalysis
AT sumbalbhatti whatistheeffectivenessofradiofrequencyablationinthemanagementofpatientswithspinalmetastasesasystematicreviewandmetaanalysis
AT pujapatel whatistheeffectivenessofradiofrequencyablationinthemanagementofpatientswithspinalmetastasesasystematicreviewandmetaanalysis
AT thomasmarshall whatistheeffectivenessofradiofrequencyablationinthemanagementofpatientswithspinalmetastasesasystematicreviewandmetaanalysis
AT tobysmith whatistheeffectivenessofradiofrequencyablationinthemanagementofpatientswithspinalmetastasesasystematicreviewandmetaanalysis
_version_ 1718442429938401280